CRISPR/cas9 genome editing is used to insert a 3Xhemagluttin tag (HA), a P2A self-cleaving peptide sequence, an cre/ERT2, a T2A site, followed by an EGFP reporter close to the TGA stop codon in exon 7. (J:337553)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count